Treatment gaps and potential cardiovascular risk reduction from expanded statin use in the US and England
<p>Background: The updated national guidelines for cardiovascular risk assessment and lipid modification in the UK and US expand the indications for statin therapy in primary prevention to adults with moderate risk of cardiovascular disease (CVD) but many adults at high CVD risk remain untrea...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Public Library of Science
2018
|